Bayer’s pharma unit is seeking new sources of growth to counteract falling revenue anticipated in coming years from ...

Bayer now says it expects to make €3 billion ... results of the phase 3 ARASENS trial in the New England Journal of Medicine. The study showed that adding Nubeqa to standard therapy with anti ...

Bayer cut its full-year earnings target after a tough agricultural market hit its crop-science division, and said it heads ...

Leadership Strategist Dan Pontefract covers leadership and culture. Heike Prinz of Bayer's Board of Management recently articulated the company's predicament, stating, "Bayer is currently in a ...

According to The Wall Street Journal, Bayer started putting in the cotton ... We've all been there: reaching for the medicine cabinet with a splitting headache, opening the new pill bottle ...

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of ...

Bayer’s Parkinson’s disease cell therapy ... circuit therapeutics and associate professor at the Icahn School of Medicine at Mount Sinai, said in the release. “New therapies with potential ...

As we usher in 2025, it’s the perfect time to prioritize health and wellness. Recently, Registered Dietitian & Nutritionist Kelly Bristow from ...